CMPK1 and breast cancer: Overexpression or mutation of CMPK1 can disrupt DNA synthesis, promoting tumor initiation and progression in BC and other malignancies.[20,21] DHODH plays a critical role in the pyrimidine metabolic pathway, and its abnormal expression or activity alterations might influence tumor cell proliferation.